elminda is Leading the Neural Revolution
17,000 Patients
540,000 standardized datasets and growing
$212 Billion
Total addressable market in the US alone
60+
Patents with innovation treatment opportunities
Driving Innovation with elminda Data Platform
BNA™ Technology provides a flywheel effect that drives further growth & market offerings as the dataset grows.
- Grows database with each new patient
- Builds clinical insight
- Develops capability and product opportunities
- Drives application adoption
The commercial launch of BNA™ will further drive data growth and insight, along with topline revenue, with each additional patient.
Leveraging Big Data, Signal Processing, & AI
ROBUST COMPETITIVE ADVANTAGE
elminda has the world’s largest Medical Grade Standardized database of EEG & ERP recordings to provide clinicians with technology to clearly and accurately interpret brain function.
ATTRACTIVE BUSINESS MODEL
Recurring revenue and established reimbursement. Platform built to develop future biomarkers and companion diagnostics allowing for the expansion of existing pharma collaborations and partnerships to bring new drugs to market.
INNOVATIVE TREATMENT OPPORTUNITIES
The first practical and feasible way for front-line clinicians to objectively measured and compare brain function (cognition). The elminda Data Platform is FDA cleared(510k) & CE marked software platform with over 7 years of clinical experience and $75M capital invested.
Breakthrough Innovation
elminda Data Platform, powered by BNA™ technology, is the world’s largest Medical Grade standardized database with near-limitless potential growth.

February 2015
August 2015
November 2018
Market Opportunities
BNA™ Potential Primary Growth Channels
1. Psychiatry
BNA™ could improve treatment of depression significantly by objectively measuring brain health, improving and saving lives.
2. Neurology
BNA™ could identify early on-set of dementia and possibly delay onset through optimised patient care.
3. Pharma Industry
BNA™ can help objectively quantify drug impact and develop patient response models.
Proven Utility Basis for Growth
Extensive previous experience provides tangible future development business opportunities.
We Invite You To Learn More
The neural revolution is multi-layered, complex and exciting – but it requires in-depth discussion and analysis of our go-to-market strategy, technology and data leadership. We encourage institutional investors to book time with our leadership team for a proper investor presentation.